propranolol has been researched along with Myasthenia Gravis in 11 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of intravenous injection of propranolol, verapamil, terbutaline, calcium, and edrophonium on neuromuscular transmission has been studied with repetitive nerve stimulation and clinical tests in 10 patients with myasthenia gravis (MG)." | 3.69 | Acute effects of intravenous injection of beta-adrenoreceptor- and calcium channel at antagonists and agonists in myasthenia gravis. ( Bjelak, S; Jonkers, I; Matell, G; Pirskanen, R; Swerup, C, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jamiołkowska, M | 1 |
| Bossowski, A | 1 |
| Weber, JC | 1 |
| Kómár, J | 2 |
| Szalay, M | 2 |
| Szél, I | 2 |
| Choi, KL | 1 |
| Wat, MS | 1 |
| Ip, TP | 1 |
| Kung, AW | 1 |
| Lam, KS | 1 |
| Jonkers, I | 2 |
| Swerup, C | 2 |
| Pirskanen, R | 2 |
| Bjelak, S | 2 |
| Matell, G | 2 |
| Van Vliet, J | 1 |
| Nicolle, MW | 1 |
| Lechin, F | 1 |
| van der Dijs, B | 1 |
| Pardey-Maldonado, B | 1 |
| John, E | 1 |
| Jimenez, V | 1 |
| Orozco, B | 1 |
| Baez, S | 1 |
| Lechin, ME | 1 |
| Herishanu, Y | 1 |
| Rosenberg, P | 1 |
| Takamori, M | 1 |
| Ishii, N | 1 |
| Mori, M | 1 |
1 trial available for propranolol and Myasthenia Gravis
| Article | Year |
|---|---|
Enhancement of noradrenergic neural transmission: an effective therapy of myasthenia gravis: a report on 52 consecutive patients.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Ad | 2000 |
10 other studies available for propranolol and Myasthenia Gravis
| Article | Year |
|---|---|
15-Year old girl with APS type IIIc, 12 months post-thymectomy remission of myasthenia.
Topics: Adolescent; Adrenergic beta-Antagonists; Female; Humans; Myasthenia Gravis; Polyendocrinopathies, Au | 2017 |
Beta-adrenoreceptor antagonists and diplopia.
Topics: Angina Pectoris; Diplopia; Drug Interactions; Humans; Male; Middle Aged; Myasthenia Gravis; Oxprenol | 1982 |
[Transient myasthenia syndrome following ingestion of a high dose of a beta-blocking agent].
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Muscles; Myasthenia Gravis; Neurosecretory Syste | 1983 |
Phaeochromocytoma associated with myasthenia gravis precipitated by propranolol treatment.
Topics: Adrenal Gland Neoplasms; Aged; Humans; Male; Myasthenia Gravis; Pheochromocytoma; Propranolol | 1995 |
Acute effects of intravenous injection of beta-adrenoreceptor- and calcium channel at antagonists and agonists in myasthenia gravis.
Topics: Adult; Aged; Edrophonium; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Organometallic Compo | 1996 |
Calcium channel and beta-receptor antagonists and agonists in MG.
Topics: Administration, Oral; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Calcium Channel Blocker | 1998 |
Pseudo-myasthenia gravis and thymic hyperplasia in Graves' disease.
Topics: Adult; Anti-Anxiety Agents; Anti-Inflammatory Agents; Antithyroid Agents; Diagnosis, Differential; F | 1999 |
Letter: beta-Blockers and myasthenia gravis.
Topics: Adrenergic beta-Antagonists; Aged; Female; Humans; Middle Aged; Myasthenia Gravis; Oxprenolol; Propr | 1975 |
[A myasthenic episode following intake of large amounts of a beta blocker].
Topics: Adult; Electromyography; Female; Humans; Muscles; Myasthenia Gravis; Propranolol; Suicide, Attempted | 1987 |
The role of cyclic 3',5'-adenosine monophosphate in neuromuscular transmission.
Topics: Acetylcholine; Action Potentials; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminophylline | 1973 |